ClinConnect ClinConnect Logo
Search / Trial NCT04091139

Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong

Launched by CHINESE UNIVERSITY OF HONG KONG · Sep 13, 2019

Trial Information

Current as of September 12, 2025

Completed

Keywords

Unified Protocol Cognitive Behavioural Therapy Depression Anxiety Adolescents

ClinConnect Summary

A Chinese treatment protocol would be developed based on the UP-A. The adolescent program consists of 8 modules, and the parent program consists of 3 modules. Similar to the work by Ehrenreich and Barlow, a flexible modular approach would be adopted, when extra sessions would be arranged to cater for individual treatment needs and heterogeneity of symptom severity. The whole treatment comprised of 10 to 12 individual sessions for the adolescents, and 4 to 6 sessions for parents or guardian. The total duration would be around 3 months. Each treatment sessions would be around 1 hour.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 13 to 18 years.
  • Primary diagnosis of any depression and/or anxiety disorders in fifth edition of the Diagnostic and Statistical Manual
  • Use Chinese as primary written language
  • For adolescents on medication, there must be 6-week stabilization period before study entry
  • Exclusion Criteria:
  • Diagnoses of psychotic disorders, organic brain disease, bipolar disorder
  • In high risk of self-harm or suicide
  • Significant cognitive impairment (intellectual quotient lower than 80)
  • Autism Spectrum Disorders
  • Externalizing disorders with serious treatment interfering disruptive behavioural problems or substance abuse
  • Attending concurrent psychotherapy
  • Experience of attending a full-course of cognitive behavior therapy for anxiety or depression

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, Hk, Hong Kong

Patients applied

0 patients applied

Trial Officials

Sophie Yan Yan Cheung, MSocSc

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials